PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.41%
Net income growth 1.25-1.5x ORCL's 8.85%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
-2.71%
Negative yoy D&A while ORCL is 4.01%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-28.35%
Negative yoy deferred tax while ORCL stands at 21.06%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-2.88%
Negative yoy SBC while ORCL is 1.65%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
117.81%
Well above ORCL's 103.45% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
55.50%
AR growth well above ORCL's 77.14%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-91.88%
Negative yoy inventory while ORCL is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
80.22%
AP growth well above ORCL's 100.32%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
155.24%
Growth well above ORCL's 107.52%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-118.69%
Negative yoy while ORCL is 48.87%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
118.75%
Operating cash flow growth below 50% of ORCL's 403.53%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-5.31%
Both yoy lines negative, with ORCL at -7.93%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
55.67%
Less M&A spending yoy vs. ORCL's 7900.00%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
21.86%
Purchases well above ORCL's 41.76%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
22.99%
We have some liquidation growth while ORCL is negative at -72.22%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-460.13%
Both yoy lines negative, with ORCL at -2.70%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
54.35%
We have mild expansions while ORCL is negative at -4.51%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment above 1.5x ORCL's 59.68%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
120.58%
We slightly raise equity while ORCL is negative at -32.88%. John Neff sees competitor possibly preserving share count or buying back shares.
-0.92%
We cut yoy buybacks while ORCL is 42.61%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.